D-0085-2018 Class II Terminated
FDA drug recall D-0085-2018 was initiated by Leading Pharma, LLC on Sep 28, 2017 and is designated Class II. Reason for recall: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 2952 500-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 29, 2017
- Initiation Date
- Sep 28, 2017
- Termination Date
- Sep 21, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2952 500-count bottles
Product description
Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05
Reason for recall
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Distribution pattern
Nationwide in the USA
Code information
Lot #E00717
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0085-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026